Treatment of Metastatic Melanoma Using Interleukin-2 Alone or in Conjunction with Vaccines

PURPOSE: To identify prognostic factors associated with survival beyond 4 years and overall response in patients with metastatic melanoma treated with high-dose bolus i.v. interleukin-2 (IL-2) given either alone or in combination with a variety of melanoma vaccines. STUDY DESIGN: 684 consecutive pat...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Smith, Franz O., Downey, Stephanie G., Klapper, Jacob A., Yang, James C., Sherry, Richard M., Royal, Richard E., Kammula, Udai S., Hughes, Marybeth S., Restifo, Nicholas P., Levy, Catherine L., White, Donald E., Steinberg, Seth M., Rosenberg, Steven A.
Format: Artigo
Sprog:Inglês
Udgivet: 2008
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2656367/
https://ncbi.nlm.nih.gov/pubmed/18765555
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-08-0116
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker